Description
Silymarin Tablets / Capsules (140 mg)
Healthy Inc is a specialized global supplier and exporter of advanced hepatology, gastroenterological, and metabolic therapeutics. We provide ultra-high-purity, pharmacopeially standardized Silymarin Film-Coated Tablets & Hard Capsules (140 mg), manufactured in WHO–GMP certified, high-precision oral solid dosage facilities. This “Clinical-Grade Hepatoprotective Agent” is a massive-volume, essential export to hepatology centers, internal medicine clinics, retail pharmacy networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally trusted intervention for toxic liver damage, fatty liver disease, and hepatic cirrhosis.
Product Overview
This formulation contains Silymarin, a highly potent, naturally derived active complex of flavonolignans (primarily silybin, silydianin, and silychristin) extracted from the seeds of the Milk Thistle plant (Silybum marianum). It acts as a powerful, multi-target shield and regenerator for failing liver tissue.
The “Hepatic Shield & Regenerator” Specialist:
- Mechanism 1 (Hepatocyte Membrane Stabilization): Silymarin physically alters the outer cell membrane structure of hepatocytes (liver cells). This prevents highly destructive hepatotoxins (such as alcohol, poisonous mushroom toxins, or harsh pharmaceuticals) from penetrating the cell interior, effectively neutralizing their toxic threat before they can cause cellular death.
- Mechanism 2 (Antioxidant & Free Radical Scavenging): A failing liver produces massive amounts of reactive oxygen species (free radicals) that destroy healthy tissue through lipid peroxidation. Silymarin acts as a profound free radical scavenger, rapidly neutralizing these toxic compounds and significantly increasing the liver’s natural supply of glutathione (the body’s master antioxidant).
- Mechanism 3 (Protein Synthesis & Regeneration): This is Silymarin’s most clinically valuable trait. Once inside the nucleus of the liver cell, it stimulates an enzyme called RNA polymerase I. This drastically accelerates the synthesis of ribosomal proteins, forcing the liver to rapidly generate new, healthy hepatocytes to replace the damaged and dying ones.
Product Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Hard Gelatin Capsule, packed in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to preserve the integrity of the highly sensitive botanical extract.
| Active Ingredient | Strength | Primary Clinical Function |
|---|---|---|
| Silymarin (Standardized Extract) BP/Ph.Eur. | 140 mg (Calculated as Silybin) | Global Clinical Standard: High-dose therapeutic management of acute and chronic liver damage. |
| Excipients | Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate | Diluent / Superdisintegrant / Binder (Engineered for optimal gastric dissolution and maximized gastrointestinal absorption of the flavonolignans) |
*Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-to-90 day chronic hepatology adherence regimens).
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers, Hepatology Distributors, and Pharmacy Chains.
| HS Code | 3004.90.11 / 3004.90.99 (Medicaments containing botanical extracts / Hepatoprotectives) |
| CAS Number | 65666-07-1 |
| Dosage Form | Film-Coated Tablet / Hard Capsule (Immediate Release) |
| Packaging | High-Density Alu-PVC or Alu-Alu Blisters. Protects the formulation from light and environmental humidity, ensuring a highly stable shelf life across Zone IVb tropical climates. |
| Storage | Store strictly below 30°C in a dry place. Protect from Light and Moisture. |
| Certificates | WHO-GMP, COPP, Free Sale Certificate |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- Strict Botanical Standardization (CRITICAL COMPLIANCE): The clinical efficacy of Silymarin is entirely dependent on the exact concentration of its active isomer, Silybin. Unregulated supplements often contain useless, unstandardized plant powder. Our clinical-grade Silymarin is strictly validated via High-Performance Liquid Chromatography (HPLC) to guarantee an exact 140 mg standardized therapeutic yield per tablet, alongside rigorous screening to ensure absolute zero presence of heavy metals, pesticides, or aflatoxins.
Therapeutic Indications (Human Use)
Indicated for the targeted management and regeneration of damaged hepatic tissue:
- Toxic Liver Damage: Supportive treatment for acute and chronic exposure to hepatotoxins (including heavy alcohol consumption, industrial chemicals, and hepatotoxic pharmaceuticals like high-dose paracetamol or statins).
- Chronic Inflammatory Liver Disease: Adjunctive therapy in the management of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
- Hepatic Cirrhosis: Long-term supportive care to slow the progression of liver fibrosis and cirrhosis.
Dosage & Administration
Recommended Dosage (Strictly as per Physician/Hepatologist Guidelines):
- Standard Adult Dosing (Initial Therapy): One 140 mg tablet taken 2 to 3 times a day (for severe liver dysfunction).
- Maintenance Dosing: Once the condition has stabilized, the dose may be reduced to one 140 mg tablet 1 to 2 times a day.
- Administration: Tablets should be swallowed whole with an adequate amount of liquid. They are optimally taken after meals to ensure smooth gastrointestinal tolerability.
Safety Warnings (CRITICAL Regulatory & Clinical Data):
- Asteraceae Allergy Contraindication: Silymarin is derived from the milk thistle plant. It is strictly contraindicated in patients with a known severe allergy to plants in the Asteraceae/Compositae family (such as ragweed, chrysanthemums, marigolds, or daisies), as it can trigger severe anaphylaxis.
- Hypoglycemia Risk (Diabetic Monitoring): Silymarin has a mild blood-sugar-lowering effect. When co-administered with antidiabetic drugs (like Metformin or Glimepiride) or insulin, it can increase the risk of hypoglycemia. Blood glucose must be monitored and diabetes medications adjusted if necessary.
- Mild Gastrointestinal Effects: The most commonly reported side effect is a mild, temporary laxative effect. Nausea or dyspepsia may rarely occur.
- Drug Interactions (CYP Inhibition): Silymarin may mildly inhibit cytochrome P450 enzymes (specifically CYP3A4 and CYP2C9). Caution is advised when co-administering with narrow-therapeutic-index drugs metabolized by these pathways.
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Retail Pharmacy Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Hepatology and Gastroenterology Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for metabolic disease clinics in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.









Reviews
There are no reviews yet.